Search Results - "HOJNACKI, D"

Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study by Bergsland, N, Ramasamy, D, Tavazzi, E, Hojnacki, D, Weinstock-Guttman, B, Zivadinov, R

“…Leptomeningeal inflammation is associated with the development of global cortical gray matter atrophy in multiple sclerosis. However, its association with…”
Get full text

Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5‐year longitudinal study by Jakimovski, D., Gandhi, S., Paunkoski, I., Bergsland, N., Hagemeier, J., Ramasamy, D. P., Hojnacki, D., Kolb, C., Benedict, R. H. B., Weinstock‐Guttman, B., Zivadinov, R.

“…Background Cardiovascular diseases (CVDs) are more frequent in multiple sclerosis (MS) patients when compared to controls. In particular, CVDs are linked with…”
Get full text

Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis by Zivadinov, R, Ramasamy, D P, Hagemeier, J, Kolb, C, Bergsland, N, Schweser, F, Dwyer, M G, Weinstock-Guttman, B, Hojnacki, D

“…Leptomeningeal contrast enhancement is found in patients with multiple sclerosis, though reported rates have varied. The use of 3D-fluid-attenuated inversion…”
Get full text

Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine by Ghione, E, Bergsland, N, Dwyer, M G, Hagemeier, J, Jakimovski, D, Paunkoski, I, Ramasamy, D P, Silva, D, Carl, E, Hojnacki, D, Kolb, C, Weinstock-Guttman, B, Zivadinov, R

“…The assessment of brain atrophy in a clinical routine is not performed routinely in multiple sclerosis. Our aim was to determine the feasibility of brain…”
Get full text

Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS by ZIVADINOV, R, MARR, K, HUNT, K, ANDREWS, M, CARL, E, DWYER, M. G, HOJNACKI, D, WEINSTOCK-GUTTMAN, B, CUTTER, G, RAMANATHAN, M, BENEDICT, R. H. B, KENNEDY, C, ELFADIL, M, YEH, A. E, REUTHER, J, BROOKS, C

“…Chronic cerebrospinal venous insufficiency (CCSVI) was recently described in patients with multiple sclerosis (MS). A subject is considered CCSVI positive if ≥…”
Get full text

Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple Sclerosis by Ghione, E, Bergsland, N, Dwyer, M G, Hagemeier, J, Jakimovski, D, Ramasamy, D P, Hojnacki, D, Lizarraga, A A, Kolb, C, Eckert, S, Weinstock-Guttman, B, Zivadinov, R

“…It is unknown whether deceleration of brain atrophy is associated with disability improvement in patients with MS. Our aim was to investigate whether patients…”
Get full text

Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test by Drake, AS, Weinstock-Guttman, B., Morrow, SA, Hojnacki, D., Munschauer, FE, Benedict, RHB

“…The MS Functional Composite (MSFC) is a continuous scale of neurological disability for patients with multiple sclerosis (MS). Cognition is represented by the…”
Get full text

Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis by Zivadinov, R, Raj, B, Ramanathan, M, Teter, B, Durfee, J, Dwyer, M G, Bergsland, N, Kolb, C, Hojnacki, D, Benedict, R H, Weinstock-Guttman, B

“…The effect of comorbidities on disease severity in MS has not been extensively characterized. We determined the association of comorbidities with MR imaging…”
Get full text

Iron Deposition on SWI-Filtered Phase in the Subcortical Deep Gray Matter of Patients with Clinically Isolated Syndrome May Precede Structure-Specific Atrophy by HAGEMEIER, J, WEINSTOCK-GUTTMAN, B, BERGSLAND, N, HEININEN-BROWN, M, CARL, E, KENNEDY, C, MAGNANO, C, HOJNACKI, D, DWYER, M. G, ZIVADINOV, R

“…Increasing evidence suggests that iron deposition is present in the later stages of MS. In this study we examined abnormal phase values, indicative of…”
Get full text

Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis by Gabelic, T, Ramasamy, D P, Weinstock-Guttman, B, Hagemeier, J, Kennedy, C, Melia, R, Hojnacki, D, Ramanathan, M, Zivadinov, R

“…The exact prevalence of WM signal abnormalities in healthy relatives of MS patients and their impact on disease development has not been fully elucidated. The…”
Get full text

Delayed Decline of Cognitive Function by Antihypertensive Agents: A Cohort Study Linked with Genotype Data by Sternberg, Zohara, Podolsky, R., Yu, J., Tian, M., Hojnacki, D., Schaller, B.

“…Background Arterial hypertension is among factors with the potential for increasing the risk of cognitive impairment in elderly subjects. However, studies…”
Get full text

Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years by Zivadinov, R., Hojnacki, D., Bergsland, N., Kennedy, C., Hagemeier, J., Melia, R., Ramasamy, D. P., Durfee, J., Carl, E., Dwyer, M. G., Weinstock-Guttman, B.

“…Background and purpose The long‐term benefit of natalizumab on brain atrophy progression in multiple sclerosis (MS) patients is unknown. Our aim was to…”
Get full text

Value of MR Venography for Detection of Internal Jugular Vein Anomalies in Multiple Sclerosis: A Pilot Longitudinal Study by ZIVADINOV, R, GALEOTTI, R, MAGNANO, C, SALVI, F, WEINSTOCK-GUTTMAN, B, ZAMBONI, P, HOJNACKI, D, MENEGATTI, E, DWYER, M. G, SCHIRDA, C, MALAGONI, A. M, MARR, K, KENNEDY, C, BARTOLOMEI, I

“…CCSVI was recently described in patients with MS. CCSVI is diagnosed noninvasively by Doppler sonography and invasively by catheter venography. We assessed the…”
Get full text

Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis by Morrow, SA, Weinstock-Guttman, B, Munschauer, FE, Hojnacki, D, Benedict, RHB

“…Background Studies in multiple sclerosis (MS) report conflicting conclusions regarding fatigue and cognition, which may partly be due to the use of small…”
Get full text

Increased tissue damage and lesion volumes in African Americans with multiple sclerosis by WEINSTOCK-GUTTMAN, B, RAMANATHAN, M, HASHMI, K, ABDELRAHMAN, N, HOJNACKI, D, DWYER, M. G, HUSSEIN, S, BERGSLAND, N, MUNSCHAUER, F. E, ZIVADINOV, R

“…African American (AA) patients with multiple sclerosis (MS) have more rapid disease progression and poorer responses to disease-modifying therapies than white…”
Get full text

Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis by Zivadinov, R, Dwyer, MG, Hussein, S, Carl, E, Kennedy, C, Andrews, M, Hojnacki, D, Heininen-Brown, M, Willis, L, Cherneva, M, Bergsland, N, Weinstock-Guttman, B

“…Objective: To determine the effects of intravenous natalizumab and intramuscular interferon beta-1a (IFNβ-1a) on the volume of white-matter (WM) lesions and…”
Get full text

Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls by Hojnacki, D, Zamboni, P, Lopez-Soriano, A, Galleotti, R, Menegatti, E, Weinstock-Guttman, B, Schirda, C, Magnano, C, Malagoni, A M, Kennedy, C, Bartolomei, I, Salvi, F, Zivadinov, R

“…Chronic cerebrospinal venous insufficiency (CCSVI) is a vascular condition characterized by anomalies of primary veins outside the skull that restrict normal…”
Get more information

Intra- and Extraluminal Structural and Functional Venous Anomalies in Multiple Sclerosis, as Evidenced by 2 Noninvasive Imaging Techniques by DOLIC, K, MARR, K, SIDDIQUI, A. H, HOJNACKI, D, WEINSTOCK-GUTTMAN, B, ZIVADINOV, R, VALNAROV, V, DWYER, M. G, CARL, E, KARMON, Y, KENNEDY, C, BROOKS, C, KILANOWSKI, C, HUNT, K

“…Chronic cerebrospinal venous insufficiency (CCSVI) is a vascular condition characterized by anomalies of the main extracranial cerebrospinal venous routes that…”
Get full text

Soluble receptor for advanced glycation end products in multiple sclerosis: A potential marker of disease severity by Sternberg, Z, Weinstock-Guttman, B, Hojnacki, D, Zamboni, P, Zivadinov, R, Chadha, K, Lieberman, A, Kazim, L, Drake, A, Rocco, P, Grazioli, E, Munschauer, F

“…Objectives To compare serum levels of the receptor for advanced glycation end products (sRAGE) between multiple sclerosis (MS) patients and healthy control…”
Get full text

Gender-related differences in MS: a study of conventional and nonconventional MRI measures by Antulov, R, Weinstock-Guttman, B, Cox, JL, Hussein, S, Durfee, J, Caiola, C, Dwyer, MG, Bergsland, N, Abdelrahman, N, Stosic, M, Hojnacki, D, Munschauer, FE, Miletic, D, Zivadinov, R

“…Background Studies showed gender-associated differences in multiple sclerosis (MS) disease evolution and in the evolution of conventional magnetic resonance…”
Get full text